Next Article in Journal
Polycomb Repressor Complex 2 in Genomic Instability and Cancer
Next Article in Special Issue
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid
Previous Article in Journal
Stonin 2 Overexpression is Correlated with Unfavorable Prognosis and Tumor Invasion in Epithelial Ovarian Cancer
Previous Article in Special Issue
Cannabinoid Receptor 1 and Fatty Acid Amide Hydrolase Contribute to Operant Sensation Seeking in Mice
 
 
Review

Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine

1
MTA-SZTE Neuroscience Research Group, University of Szeged, H-6725 Szeged, Hungary
2
Faculty of Health Sciences and Social Studies, University of Szeged, H-6726 Szeged, Hungary
3
Institute of Biochemistry, Biological Research Center, Hungarian Academy of Sciences, H-6726 Szeged, Hungary
4
Department of Neurology, Faculty of Medicine, Albert Szent-Györgyi Clinical Center, University of Szeged, H-6725 Szeged, Hungary
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2017, 18(8), 1617; https://doi.org/10.3390/ijms18081617
Received: 30 June 2017 / Revised: 18 July 2017 / Accepted: 21 July 2017 / Published: 30 July 2017
(This article belongs to the Special Issue Cannabinoid Signaling in Nervous System)
Both the kynurenine and the endocannabinoid systems are involved in several neurological disorders, such as migraine and there are increasing number of reports demonstrating that there are interactions of two systems. Although their cooperation has not yet been implicated in migraine, there are reports suggesting this possibility. Additionally, the individual role of the endocannabinoid and kynurenine system in migraine is reviewed here first, focusing on endocannabinoids, kynurenine metabolites, in particular kynurenic acid. Finally, the function of NMDA and cannabinoid receptors in the trigeminal system—which has a crucial role in the pathomechanisms of migraine—will also be discussed. The interaction of the endocannabinoid and kynurenine system has been demonstrated to be therapeutically relevant in a number of pathological conditions, such as cannabis addiction, psychosis, schizophrenia and epilepsy. Accordingly, the cross-talk of these two systems may imply potential mechanisms related to migraine, and may offer new approaches to manage the treatment of this neurological disorder. View Full-Text
Keywords: cannabinoids; endocannabinoids; cannabinoid receptors; kynurenines; opioids; migraine cannabinoids; endocannabinoids; cannabinoid receptors; kynurenines; opioids; migraine
Show Figures

Graphical abstract

MDPI and ACS Style

Nagy-Grócz, G.; Zádor, F.; Dvorácskó, S.; Bohár, Z.; Benyhe, S.; Tömböly, C.; Párdutz, Á.; Vécsei, L. Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine. Int. J. Mol. Sci. 2017, 18, 1617. https://doi.org/10.3390/ijms18081617

AMA Style

Nagy-Grócz G, Zádor F, Dvorácskó S, Bohár Z, Benyhe S, Tömböly C, Párdutz Á, Vécsei L. Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine. International Journal of Molecular Sciences. 2017; 18(8):1617. https://doi.org/10.3390/ijms18081617

Chicago/Turabian Style

Nagy-Grócz, Gábor, Ferenc Zádor, Szabolcs Dvorácskó, Zsuzsanna Bohár, Sándor Benyhe, Csaba Tömböly, Árpád Párdutz, and László Vécsei. 2017. "Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine" International Journal of Molecular Sciences 18, no. 8: 1617. https://doi.org/10.3390/ijms18081617

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop